Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NSFICorps_EL_T2
    Junior Member
    • Feb 2014
    • 2

    #1

    Hello from the NSF I-Corps Program (NYU/Columbia)

    Hello Everyone,

    I am a research scientist participating in an NSF-sponsored program called NYCRIN I-Corps, hosted jointly by Columbia University and New York University. My team and I are investigating the unique challenges facing next-gen sequencing labs. I've had the opportunity to speak to people at all levels of the sequencing ecosystem (technicians to executive directors) and have gained some valuable insights so far.

    I stumbled across this forum in the midst of my research and feel incredibly lucky that it is both active and well-organized. I've checked out posts on topics similar to mine, but couldn't find anything both big-picture and recent. Instead of just dropping a list of questions on the group, does anyone have a suggestion for a preferred sub-forum to initiate this type of conversation in your community? I'd be happy with any opportunity to talk with you all, be it forum-based, email, skype/phone, etc. Thanks in advance and I look forward to learning from you!

    -Kevin
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I'd never heard of the NYCRIN I-Corps before, it sounds like a really interesting program. Regarding a preferred sub-forum, perhaps just "General". Realistically speaking, those of us who frequent the site just follow the site-wide list of new posts (at least I do), so it probably won't matter much.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...